Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Jun 22 2021

Dermatofibrosarcoma Protuberans

  • summary
    • Dermatofibrosarcoma Protuberans are rare, low-grade fibrogenic cutaneous sarcomas that occur in early to mid-adult life.
    • Diagnosis is made with a biopsy showing uniform fibroblasts arranged in storiform pattern around an inconspicuous vasculature.
    • Treatment is usually wide surgical resection with radiation therapy.
  • Epidemiology
    • Incidence
      • accounts for 1% of soft tissue sarcomas
    • Demographics
      • slightly more common in males
      • usually presents in people aged 20-50 years old
      • more common in African Americans (2:1) vs. Caucasians
    • Anatomic location
      • trunk > proximal extremities > head/neck
  • Etiology
    • Variants 
      • Bednar tumor 
        • pigmented variant that is 7.5x more common in African Americans
      • fibrosarcomatous
        • more aggressive variant with poor prognosis
    • Genetics
      • mutations
        • associated with t(17;22)
          • encodes for PDGF-beta chain (PDGFB)/collagen type I alpha 1 (COL1A1) fusion protein
  • Symptoms
    • Presentation
      • usually an slowly enlarging painless mass
        • composed of firm irregular nodules
        • may have dark red or blue discoloration
  • Imaging
    • Radiographs
      • views
        • CXR
      • indications
        • screen for pulmonary metastasis in high-risk cases (i.e. recurrence or suspicion for a fibrosarcoma variant of DFSP)
    • CT
      • indications
        • suspected direct bone involvement or metastasis
    • MRI
      • indications
        • preoperative assessment in larger or atypical lesions and recurrent disease
    • Ultrasound
      • indications
        • monitoring of local DFSP or regional lymph node metastasis
    • PET
      • indications
        • monitoring of metastatic disease
  • Histology
    • Biopsy is required for diagnosis
    • Histology
      • classically appears as uniform fibroblasts arranged in storiform pattern around an inconspicuous vasculature
      • Bednar variant has scattered melanin-containing dendritic cells
      • fibrosarcomatous variant has a characteristic herringbone pattern
  • Treatment
    • Nonoperative
      • imatinib
        • inhibits PDGF-receptor tyrosine kinase
        • indications
          • adult patients with unresectable, recurrent, and/or metastatic DFSP
        • outcomes
          • 65% response rate
          • no response in patients who lack the t(17,22) mutation
    • Operative
      • wide surgical resection +/- adjuvant radiation therapy
        • indications
          • patients with resectable DFSP
          • adjuvant radiation therapy is useful in patients with positive margins or in whom adequate wide excision alone may result in major cosmetic or functional deficits
        • technique
          • clean margins are an important goal of surgical resection
            • obtain 2-3cm margins
            • dissect deep to and excise all tissue including the fascia
          • total dose of radiation therapy is 50-70 Gy
        • outcomes
          • 15.7% recurrence for lesions on the body
          • 51.8% recurrence rate for lesions on the head/neck
    • Location
      B. Scan

      Case A

  • Prognosis
    • Local recurrence is common
    • Distant metastasis is rare (< 5%)
      • lung is the most common site of distant metastasis
      • occurs via hematogenous spread
      • usually preceded by multiple local recurrences
    • Worse prognosis seen with
      • regional lymph node involvement
      • fibrosarcomatous progression DFSP variant
      • histologic features: high number of mitotic figures, increased cellularity, DNA aneuploidy, TP53 gene overexpression, and the presence of fibrosarcomatous changes
      • age > 50 years old
1 of 0
1 of 2
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options